https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-06-01 / J Clin Oncol 31, 2013 (suppl; abstr 3029)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-06-01 / J Clin Oncol 31, 2013 (suppl; abstr 3029)2013-06-01 00:00:002021-08-09 07:52:56Allogeneic dendritic cell (DC) vaccination as an “off the shelf” treatment to prevent or delay relapse in elderly acute myeloid leukemia patients: Results of phase I study.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2012-06-04 / J Clin Oncol 30, 2012 (suppl; abstr 2506)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2012-06-04 / J Clin Oncol 30, 2012 (suppl; abstr 2506)2012-06-04 00:00:002021-08-09 07:43:36WT1-targeted dendritic cell vaccination as a postremission treatment to prevent or delay relapse in acute myeloid leukemia.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2012-06-01 / Bull Cancer 2012 Jun;99(6):635-42
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2012-06-01 / Bull Cancer 2012 Jun;99(6):635-422012-06-01 00:00:002019-02-15 08:45:25[Dendritic cell-based therapeutic vaccination for acute myeloid leukemia]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-11-30 / Leuk. Res. 2012 May;36(5):634-45
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-11-30 / Leuk. Res. 2012 May;36(5):634-452011-11-30 00:00:002011-11-30 00:00:00Anti-leukemic activity of Newcastle disease virus strains AF2240 and V4-UPM in murine myelomonocytic leukemia in vivo
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-08-04 / Ger Med Sci 2011;9:Doc18
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-08-04 / Ger Med Sci 2011;9:Doc182011-08-04 00:00:002019-02-15 08:45:26Pulsing with blast cell lysate or blast-derived total RNA reverses the dendritic cell-mediated cytotoxic activity of cytokine-induced killer cells against allogeneic acute myelogenous leukemia cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-02-01 / Zhongguo Dang Dai Er Ke Za Zhi 2011 Feb;13(2):149-52
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-02-01 / Zhongguo Dang Dai Er Ke Za Zhi 2011 Feb;13(2):149-522011-02-01 00:00:002011-02-01 00:00:00[Roles of Newcastle disease virus in human acute monocytic leukemia in vitro and in vivo]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-07-14 / Proc. Natl. Acad. Sci. U.S.A. 2010 Aug;107(31):13824-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-07-14 / Proc. Natl. Acad. Sci. U.S.A. 2010 Aug;107(31):13824-92010-07-14 00:00:002019-02-15 08:45:27Induction of complete and molecular remissions in acute myeloid leukemia by Wilms‘ tumor 1 antigen-targeted dendritic cell vaccination
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-03-16 / Oncologist 2009 Mar;14(3):240-52
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-03-16 / Oncologist 2009 Mar;14(3):240-522009-03-16 00:00:002019-02-15 08:32:27Immunotherapy of acute myeloid leukemia: current approaches
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-02-19 / Cancer Immunol. Immunother. 2009 Oct;58(10):1669-77
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-02-19 / Cancer Immunol. Immunother. 2009 Oct;58(10):1669-772009-02-19 00:00:002019-02-15 08:32:26Dramatic efficacy improvement of a DC-based vaccine against AML by CD25 T cell depletion allowing the induction of a long-lasting T cell response
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-01 / Semin. Hematol. 2009 Jan;46(1):89-99
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-01 / Semin. Hematol. 2009 Jan;46(1):89-992009-01-01 00:00:002019-02-15 08:32:28Immunotherapy in acute leukemia
